2015 Q3 Form 10-Q Financial Statement

#000117494715001602 Filed on November 04, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2014 Q3
Revenue $120.9M $98.33M
YoY Change 22.93% -42.48%
Cost Of Revenue $86.86M $74.59M
YoY Change 16.45% -30.94%
Gross Profit $34.01M $23.74M
YoY Change 43.28% -62.28%
Gross Profit Margin 28.14% 24.14%
Selling, General & Admin $16.05M $13.78M
YoY Change 16.49% -22.89%
% of Gross Profit 47.19% 58.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.900M $8.900M
YoY Change 0.0% 85.42%
% of Gross Profit 26.17% 37.49%
Operating Expenses $16.05M $13.78M
YoY Change 16.49% -24.11%
Operating Profit $17.96M $9.960M
YoY Change 80.33% -77.76%
Interest Expense -$36.00K -$37.00K
YoY Change -2.7% -7.5%
% of Operating Profit -0.2% -0.37%
Other Income/Expense, Net $211.0K $636.0K
YoY Change -66.82% 72.83%
Pretax Income $18.17M $10.60M
YoY Change 71.5% -76.53%
Income Tax $6.209M $3.815M
% Of Pretax Income 34.17% 36.0%
Net Earnings $11.96M $6.781M
YoY Change 76.42% -76.35%
Net Earnings / Revenue 9.9% 6.9%
Basic Earnings Per Share $0.64 $0.35
Diluted Earnings Per Share $0.62 $0.34
COMMON SHARES
Basic Shares Outstanding 18.70M shares 19.42M shares
Diluted Shares Outstanding 19.37M shares 19.93M shares

Balance Sheet

Concept 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $60.30M $28.10M
YoY Change 114.59% -48.25%
Cash & Equivalents $28.05M
Short-Term Investments
Other Short-Term Assets $11.80M $9.900M
YoY Change 19.19% 1.02%
Inventory $40.80M $47.70M
Prepaid Expenses
Receivables $53.00M $45.84M
Other Receivables $0.00 $0.00
Total Short-Term Assets $165.8M $131.5M
YoY Change 26.07% -11.08%
LONG-TERM ASSETS
Property, Plant & Equipment $108.9M $103.3M
YoY Change 5.45% 24.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $18.50M $30.49M
YoY Change -39.32% 56.36%
Total Long-Term Assets $127.3M $133.8M
YoY Change -4.83% 30.5%
TOTAL ASSETS
Total Short-Term Assets $165.8M $131.5M
Total Long-Term Assets $127.3M $133.8M
Total Assets $293.1M $265.3M
YoY Change 10.49% 5.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.20M $24.60M
YoY Change 51.22% -37.88%
Accrued Expenses $32.40M $23.40M
YoY Change 38.46% -34.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $70.50M $48.98M
YoY Change 43.93% -38.85%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $100.0K $200.0K
YoY Change -50.0% -98.86%
Total Long-Term Liabilities $100.0K $200.0K
YoY Change -50.0% -98.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $70.50M $48.98M
Total Long-Term Liabilities $100.0K $200.0K
Total Liabilities $79.00M $59.10M
YoY Change 33.67% -39.57%
SHAREHOLDERS EQUITY
Retained Earnings $215.7M
YoY Change
Common Stock $24.02M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $37.88M
YoY Change
Treasury Stock Shares 4.299M shares
Shareholders Equity $214.1M $206.2M
YoY Change
Total Liabilities & Shareholders Equity $293.1M $265.3M
YoY Change 10.49% 5.94%

Cashflow Statement

Concept 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $11.96M $6.781M
YoY Change 76.42% -76.35%
Depreciation, Depletion And Amortization $8.900M $8.900M
YoY Change 0.0% 85.42%
Cash From Operating Activities $14.00M -$4.600M
YoY Change -404.35% -133.09%
INVESTING ACTIVITIES
Capital Expenditures -$8.200M -$5.900M
YoY Change 38.98% -50.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$100.0K
YoY Change -100.0%
Cash From Investing Activities -$8.300M -$6.000M
YoY Change 38.33% -48.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -6.700M -8.700M
YoY Change -22.99% -31.5%
NET CHANGE
Cash From Operating Activities 14.00M -4.600M
Cash From Investing Activities -8.300M -6.000M
Cash From Financing Activities -6.700M -8.700M
Net Change In Cash -1.000M -19.30M
YoY Change -94.82% 83.81%
FREE CASH FLOW
Cash From Operating Activities $14.00M -$4.600M
Capital Expenditures -$8.200M -$5.900M
Free Cash Flow $22.20M $1.300M
YoY Change 1607.69% -94.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Income Loss
NetIncomeLoss
45026000 USD
us-gaap Dividends Common Stock
DividendsCommonStock
15893000 USD
us-gaap Dividends Paidinkind
DividendsPaidinkind
459000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
-903000 USD
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
305000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3442000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-21542000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5054000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
27058000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
2841000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
82100 shares
us-gaap Net Income Loss
NetIncomeLoss
53387000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26693000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
26820000 USD
us-gaap Inventory Write Down
InventoryWriteDown
-1126000 USD
us-gaap Inventory Write Down
InventoryWriteDown
2615000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3442000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4193000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
157000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
8000 USD
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
-78000 USD
us-gaap Deferred Other Tax Expense Benefit
DeferredOtherTaxExpenseBenefit
511000 USD
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
32000 USD
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3247000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
956000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-22414000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
8602000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-17586000 USD
rgr Increase Decrease In Product Liability
IncreaseDecreaseInProductLiability
-101000 USD
rgr Increase Decrease In Product Liability
IncreaseDecreaseInProductLiability
-360000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-9752000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
10819000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
101000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
131000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
94949000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
30954000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24488000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28696000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
222000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
179000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-24266000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-28517000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
305000 USD
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1621000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1000000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2363000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
97000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2841000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15893000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
28728000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-19332000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-29447000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
51351000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-27010000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55064000 USD
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28054000 USD
CY2015Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
40000000 USD
CY2014Q3 us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
600000 USD
us-gaap Basis Of Accounting
BasisOfAccounting
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">NOTE 1 - BASIS OF PRESENTATION</font></p> <p style="margin: 0pt; text-align: justify; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></p> <p style="margin: 0pt; text-align: justify; text-indent: 27pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and disclosures required by accounting principles generally accepted in the United States of America for complete financial statements.</font></p> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></p> <p style="margin: 0pt; text-align: justify; text-indent: 27pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring accruals, considered necessary for a fair presentation of the results of the interim periods. Operating results for the nine months ended September 26, 2015 may not be indicative of the results to be expected for the full year ending December 31, 2015. These financial statements have been prepared on a basis that is substantially consistent with the accounting principles applied in our Annual Report on Form 10-K for the year ended December 31, 2014.</font></p> </div>
us-gaap Use Of Estimates
UseOfEstimates
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="margin: 0pt; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt; text-decoration: underline;">Use of Estimates:</font></p> <p style="margin: 0pt; text-align: justify; font-family: 'times new roman';"><font style="font-family: 'times new roman', times; font-size: 10pt;">&#160;</font></p> <p style="margin: 0pt; text-align: justify; text-indent: 27pt; font-family: 'times new roman';"><font style="font-size: 10pt; font-family: 'times new roman', times;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</font></p> </div>
CY2015Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
22814000 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
20083000 USD
CY2015Q3 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
62715000 USD
CY2014Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
68934000 USD
CY2015Q3 us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
700000 USD
us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
2500000 USD
CY2015Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1300000 USD
CY2014Q3 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
900000 USD
rgr Defined Benefit Plan Contributions By Employer For Remainder Of Fiscal Year
DefinedBenefitPlanContributionsByEmployerForRemainderOfFiscalYear
1300000 USD
rgr Estimated Cost For Defined Benefit Plans
EstimatedCostForDefinedBenefitPlans
700000 USD
us-gaap Defined Contribution Plan Administrative Expenses
DefinedContributionPlanAdministrativeExpenses
2500000 USD
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
3700000 USD
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
4600000 USD
CY2015Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.342 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.354 pure
CY2015Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8300000 USD
CY2014Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.360 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.349 pure
CY2014Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2900000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
25400000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18692755 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19398184 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
650910 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
480873 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19343665 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19879057 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.82
CY2014Q4 rgr Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
6.29
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18701530 shares
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
11963000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
6781000 USD
dei Trading Symbol
TradingSymbol
RGR
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
20600000 USD
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1400000 USD
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19417437 shares
CY2015Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
673013 shares
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
515875 shares
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19374543 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19933312 shares
CY2015Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1100000 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
40977 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
17250 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.24
rgr Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue
4.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
rgr Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageGrantDateFairValue
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
23727 shares
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.24
CY2015Q3 rgr Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue
7.96
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1200000 USD
us-gaap Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
85272 shares
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2015Q3 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
2 pure
rgr Threshold Limit Of Losses Per Transaction For Taking Insurance Coverage On Annual Basis
ThresholdLimitOfLossesPerTransactionForTakingInsuranceCoverageOnAnnualBasis
5000000 USD
rgr Threshold Limit Of Aggregate Loss For Insurance Coverage On Annual Basis Excluding New Claims From Governments Or Municipalities
ThresholdLimitOfAggregateLossForInsuranceCoverageOnAnnualBasisExcludingNewClaimsFromGovernmentsOrMunicipalities
10000000 USD
CY2014 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
USD
CY2013 us-gaap Loss Contingency Damages Sought Value
LossContingencyDamagesSoughtValue
USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
286655000 USD
dei Entity Registrant Name
EntityRegistrantName
STURM RUGER & CO INC
dei Entity Central Index Key
EntityCentralIndexKey
0000095029
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2015-09-26
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
120871000 USD
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
98327000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
398698000 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
421869000 USD
CY2015Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
86860000 USD
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
74589000 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
274781000 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
34011000 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
23738000 USD
us-gaap Gross Profit
GrossProfit
123917000 USD
us-gaap Gross Profit
GrossProfit
135214000 USD
CY2015Q3 us-gaap Selling Expense
SellingExpense
9170000 USD
CY2014Q3 us-gaap Selling Expense
SellingExpense
7586000 USD
us-gaap Selling Expense
SellingExpense
34255000 USD
us-gaap Selling Expense
SellingExpense
32069000 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6880000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6192000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21214000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22168000 USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
16050000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
13778000 USD
us-gaap Operating Expenses
OperatingExpenses
55469000 USD
us-gaap Operating Expenses
OperatingExpenses
54237000 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
17961000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
9960000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
68448000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
80977000 USD
CY2015Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-36000 USD
CY2014Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-37000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-113000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-110000 USD
CY2015Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
247000 USD
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
673000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1333000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1168000 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
211000 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
636000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1220000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1058000 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18172000 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10596000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
69668000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
82035000 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6209000 USD
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3815000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
24642000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28648000 USD
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.64
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.75
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.62
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.69
CY2015Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
CY2014Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.45
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.85
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.48
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 item

Files In Submission

Name View Source Status
0001174947-15-001602-index-headers.html Edgar Link pending
0001174947-15-001602-index.html Edgar Link pending
0001174947-15-001602.txt Edgar Link pending
0001174947-15-001602-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q-14676_rgr.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgr-20150926.xml Edgar Link completed
rgr-20150926.xsd Edgar Link pending
rgr-20150926_cal.xml Edgar Link unprocessable
rgr-20150926_def.xml Edgar Link unprocessable
rgr-20150926_lab.xml Edgar Link unprocessable
rgr-20150926_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending